Introduction: Extracorporeal membrane oxygenation (ECMO) has been effective in the treatment of H1N1-induced ARDS across the globe. However, the evidence supporting the use of ECMO in ARDS is still being collected. The intention of this study was to add a piece of puzzle to the growing body of evidence on the use of ECMO in ARDS patients.
Methods: The study included adult patients with H1N1-induced ARDS treated with ECMO at the University Hospital for Infectious Diseases in Zagreb, Croatia between October 2009 and December 2013.
Results: 17 patients with H1N1-induced ARDS treated with ECMO were included in the study. The patient cohort of the study was young with a median age of 43 years (range 23-74). The hospital mortality was 35%. Possible variables associated with mortality were analyzed and only hemolysis was found to be significant.
Conclusions: Our results confirm the usefulness of ECMO treatment in patients with H1N1-induced ARDS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5301/ijao.5000356 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-term outcomes of survivors with influenza A H1N1 virus-induced severe pneumonia and ARDS: a single-center prospective cohort study.
Front Cell Infect Microbiol
April 2024
Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Introduction: Systematic evaluation of long-term outcomes in survivors of H1N1 is still lacking. This study aimed to characterize long-term outcomes of severe H1N1-induced pneumonia and acute respiratory distress syndrome (ARDS).
Method: This was a single-center, prospective, cohort study.
Coinfection of Parvovirus B19 with Influenza A/H1N1 Causes Fulminant Myocarditis and Pneumonia. An Autopsy Case Report.
Pathogens
July 2021
Cardiovir EA-4684, Faculty of Medicine, University of Reims Champagne Ardenne, 51097 Reims, France.
Parvovirus-B19 (PVB19) is a frequent causative agent of myocarditis. For unclear reasons, viral reactivation can cause acute myocarditis, a leading cause of sudden death in the young. Influenza A/H1N1(2009) virus (IAV/H1N1) is known for causing flu/pneumonia, but the heart is rarely involved.
View Article and Find Full Text PDFLung Transplantation in Pulmonary Fibrosis Secondary to Influenza A Pneumonia.
Ann Thorac Surg
October 2019
Department of Thoracic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Electronic address:
Influenza A (H1N1) can rapidly progress to acute respiratory distress syndrome and pulmonary fibrosis. We describe a 45-year-old man with acute respiratory distress syndrome and progressive lung fibrosis secondary to H1N1 pneumonia who was treated for 45 days with venovenous extracorporeal membrane oxygenation as a rescue utility and bridge to bilateral lung transplantation. The patient was saved and lived well.
View Article and Find Full Text PDFExtracorporeal membrane oxygenation in spina bifida and (H1N1)-induced acute respiratory distress syndrome.
J Artif Organs
December 2017
Department of General and Trauma Surgery, BG University Hospital Bergmannsheil, Bürkle-de-la-Camp Platz 1, 44789, Bochum, Germany.
Acute respiratory distress syndrome (ARDS) is characterized as an acute hypoxemic and/or hypercapnic respiratory failure seen in critically ill patients and is still, although decreased over the past few years, associated with high mortality. Furthermore, ARDS may be a life-threatening complication of H1N1 pneumonia. We report on a 45-year-old spina bifida patient with confirmed H1N1 influenza virus infection causing acute respiratory failure, who was successfully weaned from 42-day veno-venous extracorporeal membrane oxygenation (vv-ECMO) treatment with an excellent outcome.
View Article and Find Full Text PDFDoes permissive hypoxaemia during extracorporeal membrane oxygenation cause long-term neurological impairment?: A study in patients with H1N1-induced severe respiratory failure.
Eur J Anaesthesiol
February 2017
From the ECMO Department Karolinska, Karolinska University Hospital and Department of Physiology and Pharmacology, Section for Anesthesiology and Intensive Care Medicine (BH, VvB), Department of Psychology, Karolinska University Hospital, Huddinge and Department of Clinical Neuroscience (CA) ECMO Department Karolinska (HK, KP, BF), Department of Neuroradiology, Karolinska University Hospital, Stockholm (MM), Department of Surgical Sciences, Radiology, Uppsala University (E-ML), Department of Surgical Sciences, Anesthesiology and Intensive Care and Hedenstierna Laboratory, Uppsala University Hospital, Uppsala (AL), Sweden.
Background: The Extracorporeal Life Support Organisation accepts permissive hypoxaemia in adult patients during extracorporeal membrane oxygenation (ECMO). The neurological long-term outcome of this approach has not yet been studied.
Objectives: We investigated the prevalence of brain lesions and cognitive dysfunction in survivors from the Influenza A/H1N1 2009 pandemic treated with permissive hypoxaemia during ECMO for severe acute respiratory distress syndrome (ARDS).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!